Research
A new Mayo Clinic study shows that integrating telomere length evaluation and genetic testing into pulmonary care can significantly change how physicians diagnose and treat pulmonary fibrosis — in some cases even redirecting the course of care.
Latest stories
AI and Digital Health
January 14, 2025
Neurosciences
January 13, 2025
AI and Digital Health
January 13, 2025
Individualized Medicine
January 9, 2025
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community